Cellular assays for high-throughput screening for modulators of Trk receptor tyrosine kinases

Jun Wang1, Michael K Hancock, Jeanne M Dudek

  • 1Invitrogen Corporation, Discovery Sciences, 501 Charmany Drive, Madison, WI 53719, USA.

Current Chemical Genomics
|February 18, 2010
PubMed

Insights

We developed novel cell-based assays for screening Trk receptor tyrosine kinases (Trk) modulators. These high-throughput assays enable the identification of potent and selective compounds targeting Trk kinases for disease research.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Trk receptor tyrosine kinases (Trk) are crucial for neurotrophin signaling, regulating cell functions.
  • Dysregulated Trk activity is implicated in various diseases.
  • There is a need for robust assays to screen Trk modulators.

Purpose of the Study:

  • To develop high-throughput cell-based assays for Trk receptor kinases.
  • To facilitate the screening and selectivity profiling of Trk kinase modulators.

Main Methods:

  • Utilized nuclear factor of activated T-cells (NFAT) beta-lactamase reporter cell lines.
  • Stably expressed full-length human Trk kinases in reporter lines.
  • Validated assays using neurotrophins, inhibitors, and TRK RNAi oligos.

Main Results:

  • Successfully developed and validated functional high-throughput cell-based assays for Trk kinases.
  • Demonstrated the utility of these assays in identifying Trk kinase modulators.
  • Confirmed assay performance with cognate neurotrophins and specific inhibitors.

Conclusions:

  • The developed assays are effective for screening and studying Trk kinase modulators.
  • These assays support the discovery of potent and selective compounds targeting Trk kinases.
  • The assays provide a valuable tool for disease research involving Trk signaling pathways.

Related Concept Videos